Asset
ADINTREVIMAB
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT04859517 | phase2_3 | terminated | 2021-04-27 | 2022-11-04 | Invivyd, Inc. | Evaluation of ADG20 for the Prevention of COVID-19 |
| NCT04805671 | phase2_3 | terminated | 2021-07-26 | 2022-02-10 | Invivyd, Inc. | Evaluation of ADG20 for the Treatment of Mild or Moderate COVID-19 |
FDA applications (0)
This company has no applications containing this asset.